DUBLIN, October 10, 2017 /PRNewswire/ --

The "Introduction to Veterinary Pharmacovigilance" conference has been added to Research and Markets' offering.

This course has been designed to provide basis training and a good introduction to those concerned with Veterinary Pharmacovigilance. New entrants, support staff we well as experienced personnel who require a better understanding of veterinary drug safety will benefit from the practical guidance provided. Key terminology will be explained and roles and responsibilities will be clarified. There will be plenty of time for interaction, questions and answers to enable participants to get a good understanding of this complex subject.

Benefits in attending:

• Gain an overview of the European regulatory framework
• Be aware of Volume IXb
• Learn about VICH
• Understand adverse event reporting
• Hear about causality assessment
• Minimise the impact of data with errors
• Know the requirements for periodic safety update reports
• Literature searches explained
• Understand the implications of the proposed EU pharmacovigilance legislation and Brexit

Who Should Attend:

This course will be beneficial for those new to veterinary pharmacovigilance, support staff and experienced personnel who require a better understanding of drug safety in their current role. Adverse event monitoring and drug safety officers together with regulatory affairs and personnel from registration departments will find this useful. seminar

Agenda:

Programme Day One

Welcome and Introduction

What is Pharmacovigilance?

• Beneficial and harmful effects of veterinary medicinal products
• Key definitions

The Current Regulatory Framework and its Global Impact

• Overview of European regulatory framework, including Volume IXb and implications of the proposed EU pharmacovigilance legislation
• Implications for global environment - link to VICH
• Practical applications of definitions

Adverse Event Reporting

• Definitions
• Impact of VICH guidelines
• Expedited vs periodic
• How to handle animal SARS
• Understanding the wider scope of pharmacovigilance

Causality Assessment

• The principles of causality assessment with practical examples
• Medical evaluation of individual reports of adverse events
• Strategies for follow up

Pharmacovigilance Case Studies

Programme Day Two

Electronic Communication in Pharmacovigilance (including VEDDRA)

Minimising the Impact of Data with Errors

Clincal Trial ADR Reporting Requirements

Literature Searches

Periodic Safety Update Reports

• Format and content of the PSUR
• Analysis of data
• Incidence calculation
• Compliance and the PSUR
• Addendum Reports
• Bridging Reports

Practical Workshops on PSURs

Discussion will take place throughout the two days

For more information about this conference visit https://www.researchandmarkets.com/research/g4wfxx/introduction_to

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets